BIO comments submitted in response to a USDA-Animal and Plant Health Inspection Service request for public comment on APHIS' new strategic plan to guide the agency's work over the next five years.
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.
BIO comments submitted in response to a USDA-Animal and Plant Health Inspection Service request for public comment on APHIS' new strategic plan to guide the agency's work over the next five years.